{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:27:16Z","timestamp":1791271636706,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jped.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:45:24Z","timestamp":1750808724000},"page":"101420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of using Elexacaftor\/Tezacaftor\/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2680-4282","authenticated-orcid":false,"given":"Guilherme da Silva","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3309-8693","authenticated-orcid":false,"given":"Carolina","family":"Rambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1220-3545","authenticated-orcid":false,"given":"Gabriela","family":"Spessatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9172-1568","authenticated-orcid":false,"given":"Mait\u00ea Milagres","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2383-0011","authenticated-orcid":false,"given":"Bruno Hernandes David","family":"Jo\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4388-1541","authenticated-orcid":false,"given":"Aline Didoni","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0913-3663","authenticated-orcid":false,"given":"Juliana Gon\u00e7alves","family":"Primon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-9450","authenticated-orcid":false,"given":"Thalita Gon\u00e7alves","family":"Picciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-5286","authenticated-orcid":false,"given":"Roberta Corr\u00eaa","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7960-3925","authenticated-orcid":false,"given":"Herberto Jos\u00e9","family":"Chong-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9332-8394","authenticated-orcid":false,"given":"Carlos Roberto Lebarbenchon","family":"Massignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8431-1997","authenticated-orcid":false,"given":"Luiz Vicente Ribeiro Ferreira da","family":"Silva-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-3327","authenticated-orcid":false,"given":"Carlos Ant\u00f4nio","family":"Riedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-8051","authenticated-orcid":false,"given":"Nelson Augusto Ros\u00e1rio","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-4598","authenticated-orcid":false,"given":"D\u00e9bora Carla","family":"Chong-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jped.2025.05.007_bib0001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s1806-37562017000000065","article-title":"Brazilian guidelines for the diagnosis and treatment of cystic fibrosis","volume":"43","author":"Athanazio","year":"2017","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic Fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jped.2025.05.007_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcf.2007.03.006","article-title":"Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients","volume":"7","author":"Raskin","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jped.2025.05.007_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ph16030410","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis","volume":"16","author":"Bacalhau","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jped.2025.05.007_bib0005","first-page":"3066","article-title":"Analyzis of the epidemiology of cystic fibrosis and the application of molecular diagnostic in Brazil from 2009 to 2018","volume":"11","author":"Bezerra","year":"2023","journal-title":"Rev Interfaces"},{"key":"10.1016\/j.jped.2025.05.007_bib0006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13052-021-01060-1","article-title":"Elevated sweat chloride test: is it always cystic fibrosis?","volume":"47","author":"Cimbalo","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jped.2025.05.007_bib0007","first-page":"37","article-title":"Cystic fibrosis in low and middle-income countries (LMIC): a view from four different regions of the world","volume":"38","author":"da Silva Filho","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jped.2025.05.007_bib0008","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/jpm12091528","article-title":"Trikafta-extending its success to less common mutations","volume":"12","author":"Bentur","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jped.2025.05.007_bib0009","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/ppul.27125","article-title":"Effectiveness and safety of elexacaftor\/tezacaftor\/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting","volume":"59","author":"Dacc\u00f2","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jped.2025.05.007_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1590\/S1806-37132007000400008","article-title":"New reference values for forced spirometry in white adults in Brazil","volume":"33","author":"Pereira","year":"2007","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jped.2025.05.007_bib0012","first-page":"554","article-title":"Efficacy and safety of Elexacaftor-Tezacaftor-Ivacaftor in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Kapouni","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jped.2025.05.007_bib0013","first-page":"238","article-title":"Genetic studies on cystic fibrosis in Brazil: a systematic review","volume":"14","author":"Mota","year":"2015","journal-title":"Rev Cienc Med Biol"},{"key":"10.1016\/j.jped.2025.05.007_bib0014","article-title":"Cystic fibrosis-related mortality trends in Brazil for the 1999-2017 period: a multiple-cause-of-death study","volume":"47","author":"Santo","year":"2021","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0015","article-title":"Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians","volume":"54","author":"Terlizzi","year":"2024","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.jped.2025.05.007_bib0016","article-title":"Cystic fibrosis in Brazil: achievements in survival","volume":"47","author":"Vendrusculo","year":"2021","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0017","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade. Relat\u00f3rio de Recomenda\u00e7\u00e3o. [Cited 2025 Jan 29]. Available from: https:\/\/www.gov.br\/conitec\/pt-br"},{"key":"10.1016\/j.jped.2025.05.007_bib0018","series-title":"WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","first-page":"312","year":"2006"},{"key":"10.1016\/j.jped.2025.05.007_bib0019","series-title":"Canadian clinical consensus guideline for initiation, monitoring and discontinuation of CFTR modulator therapies for patients with cystic fibrosis","first-page":"49","year":"2024"},{"key":"10.1016\/j.jped.2025.05.007_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","article-title":"ECFS standards of care on CFTR-related disorders: updated diagnostic criteria","volume":"21","author":"Castellani","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jped.2025.05.007_bib0021","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcf.2023.09.008","article-title":"Standards for the care of people with cystic fibrosis (CF): a timely and accurate diagnosis","volume":"22","author":"Castellani","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jped.2025.05.007_bib0022","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1590\/S1806-37132009000900006","article-title":"Respiratory patterns in spirometric tests of adolescents and adults with cystic fibrosis","volume":"35","author":"Ziegler","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1590\/S0102-35862001000300002","article-title":"[Spirometry evolution assessment of cystic fibrosis]","volume":"27","author":"Andrade","year":"2001","journal-title":"J Pneumol"},{"key":"10.1016\/j.jped.2025.05.007_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jped.2025.05.007_bib0025","first-page":"18","article-title":"Multi-resistant pseudomonas aeruginosa ST235 in cystic fibrosis","volume":"27","author":"Lee","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jped.2025.05.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114176","article-title":"Reported adverse events in a multicenter cohort of patients ages 6-18 years with cystic fibrosis and at least one F508del allele receiving Elexacaftor\/Tezacaftor\/Ivacaftor","volume":"274","author":"Terlizzi","year":"2024","journal-title":"J Pediatr"},{"key":"10.1016\/j.jped.2025.05.007_bib0027","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1590\/S0102-311X2013001200006","article-title":"[Sensitivity and specificity of the patient health questionnaire-9 (PHQ-9) among adults from the general population]","volume":"29","author":"Santos","year":"2013","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.jped.2025.05.007_bib0028","article-title":"Evidence of validity of the GAD-7 Scale in brazilian adolescents","volume":"7","author":"Leite","year":"2022","journal-title":"Psico USF"},{"key":"10.1016\/j.jped.2025.05.007_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755725000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755725000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:23:04Z","timestamp":1780561384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021755725000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0021755725000981"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2025.05.007","relation":{},"ISSN":["0021-7557"],"issn-type":[{"value":"0021-7557","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of using Elexacaftor\/Tezacaftor\/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Pediatria.","name":"copyright","label":"Copyright"}],"article-number":"101420"}}